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group membeiship based on clinical symptoms. Comparable individually fitted air-conduction hearing aid and BAHA was
with this test, the headshake-impulse test has been put forward performed using audiometrie tests and a questionnaire. The
as a relevant simple test o f the vestibular system at higher results of the speech recognition-in-noise test showed a sig-
frequeneies, It is supposed to have a better relationship with nificant improvement with the BAHA. This improvement was
clinical symptoms than caloric tests and to be able to detect related to the size of the air—bone gap. The questionnaire
the side oí vestibular pathology during clinical examination.
Non-syndromal autosomal dominant hearing loss
11. A . M .  M A R R E S ,  H . P . M .  K U N S T ,  P . L . M .  I I U Y G E N  & 
C ' . W . R . J .  C R K M E R S
Sixteen forms of non-syndromal inherited hearing loss have 
been reported. Six of these can be distinguished clinically by
demonstrated that the majority of the patients preferred the 
BAHA, most probably because fewer ear infections occurred. 
There was no evident preference in speech recognition.
When an air conduction hearing aid cannot be fitted, a 
BAHA is an alternative. Preoperative assessment of the size 
of the air-bone gap may be useful in predicting fitting results. 
It is important to inform the patient of the possibility of  
inferior subjective speech recognition.
means o f type of v. gram, date of onset and/or severity
and have an autosomal dominant mode of Cisplatin ototoxi 
inheritance. Recent investigations have revealed several gene effect of a-MSH
localizations, lor example on chromosomes lp, 5q and 7p.
Two large ited f ated in a study to define
hearing loss, to investigate vestibular function and to initiate 
ne ne- loca 1 i/a t i o n s t ud ies.
P . S .  H E I J M E N ,  S . F . L .  K L I S ,  J . C . M . J .  D E  G R O O T  &
g . f .  s m o o r e n b u r g  (Utrecht)
Neuro- and ototoxicity are the dose-limiting side-effects o f  
cisplatin (cw-diaminedichloroplatinum II). Neurotoxicity can 
be delayed or prevented by simultaneous treatment with 
melanocortin-derived peptides like ORG 2766 and a-MSH. 
Recently, our group has found that also cisplatin ototoxicity 
can be reduced or prevented with ORG 2766. The present 
study was designed to investigate further the ameliorating 
effects of ORG 2766 on cisplatin ototoxicity and to evaluate 
the possibly similar effects of the physiologically more relevant 
parent peptide a-MSH.
Guinea pigs were injected (i.p.) with 2 mg/kg cisplatin for 
of progression of 8 consecutive days. a-MSH (75 mg/kg), ORG 2766 (75 
gene on chromosome 1 p seems mg/kg), or saline (controls) was given subcutaneously immedi- 
to play an important role in non-syndromal inherited hearing ately before the cisplatin injection and an extra dose was given
on day 9. Electrocochleography and hair cell counts were
In family A (n — 179) 109 people were examined. Hearing 
loss could be attributed to an inherited cause in 44 persons. 
This number wras 30 in family B (// =  129) in which 102 people 
were examined. No signs indicating an associated vestibular 
hypofunction were found. Linear regression analysis revealed 
an annual threshold increase o f 1 dB in all frequencies with a 
s
in both families and resulted in Rene localization on chro­
mosome Ip.
ses o f audiologieal studies o f a fie persons in one
f
hearing loss.
r anchored hearing aid and 
hearing aid compared
air
1',. A . M .  M Y I . A N U S ,  C . T . M ,  V A N  D E R  I ' O l t W ,  A . I ' . M .  S N I K
& C ' . W. R . J .  C R H M H R S
Increasingly, more patients cannot use air-con-
Cisplatin treatment and saline co-administration caused 
severe hearing loss ( + 60 dB at 8 kHz) combined with basal 
and medial turn hair cell loss in five out of six animals. 
However, in both the ORG 2766 and the a-MSH co-treated 
groups, three out of six animals could be classified as normal. 
We conclude that the effects of a-MSH and ORG 2766 co­
treatment are comparable and that a-MSH might be clinically 
useful in protection against cisplatin-induced ototoxicity.
' a r aid any longer change over to the BAHA
directly. The i
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¡ transition is more
to predict. Until recently, audiometric results with
compared to the air conduction hearing aid were The perception of speech-in-noise by children
j . h . p a p e  & n . p .  w i t  (Groningen)
Children with a conductive or sensorineural hearing loss have
ms. The small number of patients in a variety of
ill this study, the audiometrie results of 34 patients
with a BAHA are presented. Patients’ performance with the less intelligible speech. Some children with normal pure-tone
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